Latest Revenue Generation News

Resonance Health reports record $14.9M cash receipts over 12 months and completes cost-cutting measures while advancing two major pharma clinical trials on schedule.

LTR Pharma reports strong Q1 2025 progress with FDA pre-IND meeting success, scientific acclaim for SPONTAN’s rapid absorption, and strategic launch of ROXUS to fast-track US market entry.

Brightstar Resources reported robust March quarter results, highlighted by Second Fortune’s transition to full production and the commencement of Fish mine development, underpinning a clear growth trajectory.

Humm Group Limited has reported a remarkable 119% increase in cash profit after tax for the half-year ended December 31, 2024, alongside improved capital efficiency and reduced operating expenses. The company declared a fully franked interim dividend, underscoring its strengthened financial position.

Health and Plant Protein Group Limited has dramatically reduced its half-year net loss to $43,000 following the divestment of its macadamia division, though uncertainty lingers over a significant IRS receivable in the US.

Health and Plant Protein Group Limited reported a significantly reduced net loss of $43,000 for the half-year ended December 31, 2024, compared to a $748,000 loss in the prior period, despite no operational revenue following the sale of its macadamia division.

Mighty Kingdom has completed a strategic review, trimming $2.5 million in annual costs without disrupting current contracts and positioning itself for new revenue growth.

Artrya Limited has launched a A$15 million capital raising to fund the development and commercial rollout of its Salix AI-powered coronary artery disease diagnostic platform, targeting the lucrative US healthcare market.

AMP Limited’s FY24 Data Pack outlines a solid underlying profit performance despite headwinds, with key insights into its banking, platform, and wealth management divisions.

Tamboran Resources Corporation posted a $20 million net loss for the half year ending December 31, 2024, reflecting intensified exploration and development activities in the Beetaloo Basin amid no revenue generation. The company’s cash reserves declined to $59.4 million, underscoring the pressing need for additional capital to fund ongoing projects.

Avenira Limited has ended its licensing agreement with Aleees, freeing the company to focus on a phased development of its Wonarah Phosphate Project aimed at early revenue generation in late 2025.

Horizon Minerals has commenced processing the first ore from its Phillips Find Gold Project, marking a key milestone in its path to gold production. The joint venture with BML Ventures is progressing well, with mining operations already delivering substantial volumes.